For patients with agitation associated with dementia due to Alzheimer's disease,
When redirection isn't enough, REXULTI® (brexpiprazole) is proven to reduce the frequency of agitation symptoms
Limitations of Use: REXULTI is not indicated as an as needed (“prn”) treatment for agitation associated with dementia due to Alzheimer’s disease.
Actor portrayals.
Explore Pivotal Study Data
Review Extension Study Data
See safety profile
View dosing and titration
Please see FULL PRESCRIBING INFORMATION,
including BOXED WARNING.
including BOXED WARNING.